BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CTN Dissemination Library - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CTN Dissemination Library
X-ORIGINAL-URL:https://ctnlibrary.org
X-WR-CALDESC:Events for CTN Dissemination Library
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260225T110000
DTEND;TZID=UTC:20260225T123000
DTSTAMP:20260423T003600
CREATED:20260211T230241Z
LAST-MODIFIED:20260211T230241Z
UID:7866-1772017200-1772022600@ctnlibrary.org
SUMMARY:Western States Node: Problems Initiating Buprenorphine Treatment Among Patients Using Fentanyl (CTN-0135)
DESCRIPTION:Join the CTN Western States Node and the Northwest and Pacific Southwest Addiction Technology Transfer Centers (ATTCs) for their next joint webinar! \nIn this session\, Erin Winstanley\, PhD (CTN Appalachian Node)\, will describe a NIDA Clinical Trials Network study\, CTN-0135\, examining clinician-reported challenges with initiating buprenorphine for people using fentanyl\, including precipitated or prolonged withdrawal\, patient reports that buprenorphine was ineffective\, and patient preference for methadone. In response to these challenges\, most clinicians surveyed reported modifying their standard induction protocols or patient counseling approaches. Clinicians treating larger patient volumes\, seeing a high proportion of patients using fentanyl\, or initiating treatment in non-inpatient settings were more likely to report difficulties starting patients on buprenorphine. Dr. Winstanley will present the study results and discuss their implications. \n1.5 CME/CE credits available! For information about credit types and accreditation\, as well as learning objectives for this session\, download the webinar flyer.
URL:https://ctnlibrary.org/event/western-states-node-problems-initiating-buprenorphine-treatment-among-patients-using-fentanyl-ctn-0135/
LOCATION:Webinar/Virtual
END:VEVENT
END:VCALENDAR